{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:12:43Z","timestamp":1793819563115,"version":"4.6.1"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030829","name":"Nestl\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010886","name":"Nestl\u00e9 Health Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.obpill.2025.100228","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T11:52:28Z","timestamp":1763034748000},"page":"100228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-5772","authenticated-orcid":false,"given":"J.L.","family":"Sievenpiper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-2065","authenticated-orcid":false,"given":"M.","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-7010","authenticated-orcid":false,"given":"J.B.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5025-5448","authenticated-orcid":false,"given":"L.","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lecube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.J.","family":"Lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mittendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.H.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-2277","authenticated-orcid":false,"given":"D.H.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vilsb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2025.100228_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/obr.12551","article-title":"Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation","volume":"18","author":"Bray","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib2","first-page":"s176","article-title":"Obesity: definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.obpill.2025.100228_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/oby.22173","article-title":"Prevalence and determinants of engagement with obesity care in the United States","volume":"26","author":"Stokes","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.obpill.2025.100228_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.orcp.2022.08.003","article-title":"The Australian obesity management algorithm: a simple tool to guide the management of obesity in primary care","volume":"16","author":"Markovic","year":"2022","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.obpill.2025.100228_bib6","author":"Pedersen"},{"key":"10.1016\/j.obpill.2025.100228_bib7","article-title":"Introduction and methodology: standards of care in overweight and Obesity-2025","volume":"13","author":"Bannuru","year":"2025","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.obpill.2025.100228_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/apt.17856","article-title":"Review article: pharmacologic management of obesity - updates on approved medications, indications and risks","volume":"59","author":"Lupianez-Merly","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.obpill.2025.100228_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"Muller","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.obpill.2025.100228_bib10","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.obpill.2025.100228_bib12","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI25483","article-title":"Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure","volume":"117","author":"Hansotia","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.obpill.2025.100228_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/DMSO.S387116","article-title":"The efficacy of GLP-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: systematic review of randomized controlled trials","volume":"16","author":"Aldawsari","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.obpill.2025.100228_bib16","article-title":"Tirzepatide for obesity treatment and diabetes prevention","author":"Jastreboff","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/jobe\/3442754","article-title":"Weight loss efficacy of tirzepatide compared to placebo or GLP-1 receptor agonists in adults with obesity or overweight: a meta-analysis of randomized controlled trials with >\/= 20 weeks treatment duration","volume":"2025","author":"Khawaji","year":"2025","journal-title":"J Obes"},{"key":"10.1016\/j.obpill.2025.100228_bib18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamainternmed.2024.2525","article-title":"Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity","volume":"184","author":"Rodriguez","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.obpill.2025.100228_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.33326","article-title":"One-year weight reduction with semaglutide or liraglutide in clinical practice","volume":"7","author":"Gasoyan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100228_bib22","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100228_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-025-01859-6","article-title":"Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis","author":"Ismaiel","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.obpill.2025.100228_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.obpill.2025.100228_bib25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.metabol.2016.03.009","article-title":"Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover study","volume":"65","author":"Farr","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.obpill.2025.100228_bib26","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/dom.13827","article-title":"Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: implications for plateauing weight loss in response to anti-obesity therapies","volume":"21","author":"Farr","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100228_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1095753","article-title":"Effect of dual glucose-dependent insulinotropic peptide\/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity","volume":"14","author":"Zaffina","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.obpill.2025.100228_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.838410","article-title":"Recent advances in incretin-based pharmacotherapies for the treatment of obesity and diabetes","volume":"13","author":"Tan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.obpill.2025.100228_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/oby.24027","article-title":"Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery","volume":"32","author":"Hall","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100228_bib34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metabol"},{"issue":"suppl 1","key":"10.1016\/j.obpill.2025.100228_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/db23-128-OR","article-title":"128-OR: the effect of tirzepatide during weight loss on food intake, appetite, food preference, and food craving in people with obesity","volume":"72","author":"Martin","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.obpill.2025.100228_bib36","article-title":"Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity","author":"Mechanick","year":"2024","journal-title":"Obes Rev"},{"issue":"Suppl 4","key":"10.1016\/j.obpill.2025.100228_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100228_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00272-9","article-title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","author":"Prado","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.obpill.2025.100228_bib39","article-title":"Obesity and malnutrition in children and adults: a clinical review","volume":"8","author":"Bradley","year":"2023","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100228_bib40","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/jama.2019.17297","article-title":"Medical students around the world poorly trained in nutrition","volume":"322","author":"Abbasi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100228_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1503\/cmaj.160043","article-title":"The physician's role in cultivating healthful lifestyles","volume":"188","author":"Freedhoff","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.obpill.2025.100228_bib42","author":"Rundle"},{"key":"10.1016\/j.obpill.2025.100228_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12875-022-01811-x","article-title":"Primary care physicians' knowledge and attitudes about obesity, adherence to treatment guidelines and association with confidence to treat obesity: a Swedish survey study","volume":"23","author":"Carrasco","year":"2022","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.obpill.2025.100228_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/oby.24331","article-title":"Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status","author":"Gasoyan","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib45","unstructured":"Mailhac A, Pedersen L, Petersen I, Potteg\u00e5rd A, S\u00f8rensen HT, Thomsen RW. Discontinuation of semaglutide therapy for weight loss: population-based study of the first 77,310 users in Denmark. Presented at: European association for the study of diabetes (EASD) annual meeting; September 15-19, 2025; Vienna, Austria."},{"key":"10.1016\/j.obpill.2025.100228_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/0144341970170401","article-title":"Delphi: a technique to harness expert opinion for critical decision-making tasks in education","volume":"17","author":"Clayton","year":"1997","journal-title":"Educ Psychol"},{"key":"10.1016\/j.obpill.2025.100228_bib47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.obpill.2025.100228_bib48","author":"Brown"},{"key":"10.1016\/j.obpill.2025.100228_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.obpill.2025.100228_bib50","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000527131","article-title":"Obesity in adults: a 2022 adapted clinical practice guideline for Ireland","volume":"15","author":"Breen","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2025.100228_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-023-05894-8","article-title":"Evidence-based European recommendations for the dietary management of diabetes","volume":"66","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.obpill.2025.100228_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000528083","article-title":"European association for the study of obesity position statement on medical nutrition therapy for the management of overweight and obesity in adults developed in collaboration with the European Federation of the associations of dietitians","volume":"16","author":"Hassapidou","year":"2023","journal-title":"Obes Facts"},{"issue":"Suppl 3","key":"10.1016\/j.obpill.2025.100228_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.obpill.2025.100228_bib54","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib55","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.obpill.2025.100228_bib56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dc10-1288","article-title":"Reduction in the incidence of type 2 diabetes with the mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial","volume":"34","author":"Salas-Salvado","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100228_bib57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/dc18-0836","article-title":"Effect of a lifestyle intervention program with energy-restricted mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-plus trial","volume":"42","author":"Salas-Salvado","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100228_bib58","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/10408398.2019.1565281","article-title":"Mediterranean diet, cardiovascular disease and mortality in diabetes: a systematic review and meta-analysis of prospective cohort studies and randomized clinical trials","volume":"60","author":"Becerra-Tomas","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib59","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00125-022-05760-z","article-title":"Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials","volume":"65","author":"Massara","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.obpill.2025.100228_bib60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.clnu.2018.05.032","article-title":"Effect of vegetarian dietary patterns on cardiometabolic risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Viguiliouk","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnut.2019.00080","article-title":"Relation of vegetarian dietary patterns with major cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies","volume":"6","author":"Glenn","year":"2019","journal-title":"Front Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu11020338","article-title":"DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses","volume":"11","author":"Chiavaroli","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","article-title":"Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials","volume":"61","author":"Chiavaroli","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.obpill.2025.100228_bib64","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/CIRCULATIONAHA.123.065551","article-title":"Portfolio diet score and risk of cardiovascular disease: findings from 3 prospective cohort studies","volume":"148","author":"Glenn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.obpill.2025.100228_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2337\/dc22-1029","article-title":"The portfolio diet and incident type 2 diabetes: findings from the women's health initiative prospective cohort study","volume":"46","author":"Glenn","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100228_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093131","article-title":"Food-based dietary guidelines around the world: a comparative analysis to update AESAN scientific committee dietary recommendations","volume":"13","author":"Camara","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100221","article-title":"Perspective: beyond the mediterranean diet-exploring Latin American, Asian, and African heritage diets as cultural models of healthy eating","volume":"15","author":"LeBlanc","year":"2024","journal-title":"Adv Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/nu17121947","article-title":"A comparative analysis of graphic models for enhancing nutrition education","volume":"17","author":"Jodkiewicz","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib69","doi-asserted-by":"crossref","first-page":"899","DOI":"10.15288\/jsad.2012.73.899","article-title":"Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases","volume":"73","author":"Grodensky","year":"2012","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.obpill.2025.100228_bib70","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1080\/10408398.2021.1925221","article-title":"Association between alcohol intake and overweight and obesity: a systematic review and dose-response meta-analysis of 127 observational studies","volume":"62","author":"Golzarand","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jhn.12583","article-title":"Different associations between body composition and alcohol when assessed by exposure frequency or by quantitative estimates of consumption","volume":"31","author":"Lean","year":"2018","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100228_bib72","first-page":"27","article-title":"Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care","volume":"59","author":"Vallis","year":"2013","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.obpill.2025.100228_bib73","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.111.087213","article-title":"Energy balance and obesity","volume":"126","author":"Hill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.obpill.2025.100228_bib74","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/clinem\/dgae775","article-title":"Weight loss induces changes in vitamin D status in women with obesity but not in men: a randomized clinical trial","volume":"110","author":"Holt","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.obpill.2025.100228_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000519503","article-title":"Malnutrition in obesity: is it possible?","volume":"15","author":"Kobylinska","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2025.100228_bib76","first-page":"1","article-title":"Challenges in identifying malnutrition in obesity; an overview of the state of the art and directions for future research","author":"Mwala","year":"2024","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib77","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/oby.24067","article-title":"Nutritional considerations with antiobesity medications","volume":"32","author":"Almandoz","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib78","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/oby.2011.262","article-title":"Lower than predicted resting metabolic rate is associated with severely impaired cardiorespiratory fitness in obese individuals","volume":"20","author":"Miller","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib79","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jand.2022.11.014","article-title":"Medical nutrition therapy interventions provided by dietitians for adult overweight and obesity management: an academy of nutrition and Dietetics Evidence-Based Practice Guideline","volume":"123","author":"Morgan-Bathke","year":"2023","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100228_bib80","article-title":"Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: a qualitative research study with registered dietitians","volume":"12","author":"Despain","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100228_bib81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000515381","article-title":"European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis","volume":"14","author":"Muscogiuri","year":"2021","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2025.100228_bib82","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1249\/MSS.0000000000003520","article-title":"Physical activity and excess body weight and adiposity for adults. American college of sports medicine consensus statement","volume":"56","author":"Jakicic","year":"2024","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.obpill.2025.100228_bib83","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100228_bib84","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy weight loss maintenance with exercise, liraglutide, or both combined","volume":"384","author":"Lundgren","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","article-title":"Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial","volume":"22","author":"Sandsdal","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.obpill.2025.100228_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102475","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial","volume":"69","author":"Jensen","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2025.100228_bib87","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","article-title":"Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial","volume":"29","author":"Wadden","year":"2023","journal-title":"Nat Med"},{"issue":"Suppl 4","key":"10.1016\/j.obpill.2025.100228_bib88","article-title":"Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group","volume":"22","author":"Oppert","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072473","article-title":"Weight loss strategies and the risk of skeletal muscle mass loss","volume":"13","author":"McCarthy","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2025.100228_bib91","first-page":"27","article-title":"Protein requirement in obesity","volume":"28","author":"Weijs","year":"2025","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.obpill.2025.100228_bib92","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.obpill.2025.100228_bib93","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7861\/clinmed.2023-0168","article-title":"Causes of obesity: a review","volume":"23","author":"Masood","year":"2023","journal-title":"Clin Med (Lond)"},{"issue":"Suppl 9","key":"10.1016\/j.obpill.2025.100228_bib94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy--a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.obpill.2025.100228_bib95","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/QAD.0000000000003950","article-title":"Choice of antiretroviral therapy has low impact on weight gain","volume":"38","author":"Drechsler","year":"2024","journal-title":"AIDS"},{"key":"10.1016\/j.obpill.2025.100228_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13543","article-title":"Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials","volume":"24","author":"Alkhezi","year":"2023","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib97","article-title":"A real-world study of the effectiveness and safety of semaglutide for weight loss","volume":"16","author":"Tzoulis","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.obpill.2025.100228_bib98","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/oby.23859","article-title":"Medications and conditions associated with weight loss in patients prescribed semaglutide based on real-world data","volume":"31","author":"Powell","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib99","doi-asserted-by":"crossref","DOI":"10.2196\/43869","article-title":"The association between goal setting and weight loss: prospective analysis of a community weight loss program","volume":"25","author":"Wren","year":"2023","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.obpill.2025.100228_bib100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/00325481.2022.2051366","article-title":"What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review","volume":"134","author":"Horn","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.obpill.2025.100228_bib101","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100228_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103464","article-title":"Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis","volume":"88","author":"Chu","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2025.100228_bib103","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11606-018-4465-z","article-title":"Prevalence and correlates of disordered eating behaviors among young adults with overweight or obesity","volume":"33","author":"Nagata","year":"2018","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.obpill.2025.100228_bib104","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jand.2024.10.023","article-title":"Incretin-based therapies and lifestyle interventions: the evolving role of registered Dietitian nutritionists in obesity care","volume":"125","author":"Gigliotti","year":"2025","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100228_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/ewjm.172.3.164","article-title":"The SCOFF questionnaire: a new screening tool for eating disorders","volume":"172","author":"Morgan","year":"2000","journal-title":"West J Med"},{"key":"10.1016\/j.obpill.2025.100228_bib106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1525-1497.2003.20374.x","article-title":"Four simple questions can help screen for eating disorders","volume":"18","author":"Cotton","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.obpill.2025.100228_bib107","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.obpill.2025.100228_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13013","article-title":"Third-wave cognitive behaviour therapies for weight management: a systematic review and network meta-analysis","volume":"21","author":"Lawlor","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib110","series-title":"Nutrients in drinking water","first-page":"2005","year":"2005"},{"key":"10.1016\/j.obpill.2025.100228_bib111","first-page":"1459","article-title":"European food safety authority scientific opinion on dietary reference values for water","volume":"8","year":"2010","journal-title":"EFSA J"},{"key":"10.1016\/j.obpill.2025.100228_bib112","series-title":"Dietary reference intakes for water, potassium, sodium, chloride, and sulfate","first-page":"2005","year":"2005"},{"key":"10.1016\/j.obpill.2025.100228_bib113","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1747-0080.12697","article-title":"Total water intake by kilogram of body weight: analysis of the Australian 2011 to 2013 National Nutrition and Physical Activity Survey","volume":"78","author":"Mallett","year":"2021","journal-title":"Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100228_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.576974","article-title":"The effect of hydration on urine color objectively evaluated in CIE l(\u2217)a(\u2217)b(\u2217) color space","volume":"7","author":"Belasco","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ejhf.3244","article-title":"Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC","volume":"26","author":"Mullens","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.obpill.2025.100228_bib116","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/ndt\/gfab036","article-title":"Water intake and progression of chronic kidney disease: the CKD-REIN cohort study","volume":"37","author":"Wagner","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.obpill.2025.100228_bib117","article-title":"Obesity pillars roundtable: excessive weight reduction with highly effective anti-obesity medications (heAOMs)","volume":"4","author":"Bays","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100228_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103209","article-title":"The health benefits of dietary fibre","volume":"12","author":"Barber","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib119","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/15598276231167778","article-title":"The importance of dietary fiber for metabolic health","volume":"17","author":"Bulsiewicz","year":"2023","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.obpill.2025.100228_bib120","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100228_bib121","article-title":"Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities","author":"Bettadapura","year":"2024","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.obpill.2025.100228_bib122","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib123","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae164","article-title":"Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments","volume":"8","author":"Tinsley","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.obpill.2025.100228_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2024.104486","article-title":"Sculpting success: the importance of diet and physical activity to support skeletal muscle health during weight loss with new generation anti-obesity medications","volume":"8","author":"Grosicki","year":"2024","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clnesp.2022.01.014","article-title":"Calculation of protein requirements; a comparison of calculations based on bodyweight and fat free mass","volume":"48","author":"Dekker","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.obpill.2025.100228_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/nu14040892","article-title":"The use of portion control plates to promote healthy eating and diet-related outcomes: a scoping review","volume":"14","author":"Jia","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib127","first-page":"SP226","article-title":"CHAPTER 2. Clinical nutrition guideline for overweight and obese adults with type 2 diabetes (T2D) or prediabetes, or those at high risk for developing T2D","volume":"24","author":"Hamdy","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.obpill.2025.100228_bib128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13668-024-00548-6","article-title":"Nutritional considerations during major weight loss therapy: focus on optimal protein and a low-carbohydrate dietary pattern","volume":"13","author":"Volek","year":"2024","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.obpill.2025.100228_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society","author":"Mozaffarian","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib130","article-title":"Application of nutrition interventions with GLP-1 based therapies: a narrative review of the challenges and solutions","volume":"16","author":"Fitch","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100228_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/nu16172993","article-title":"Comparison of the nutritional adequacy of current food-based very low energy diets: a review and nutritional analysis","volume":"16","author":"Poon","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100228_bib132","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00125-021-05577-2","article-title":"Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission","volume":"65","author":"Churuangsuk","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.obpill.2025.100228_bib133","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13751","article-title":"Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre-diabetes and features of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Noronha","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib134","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2337\/dc18-2270","article-title":"The effect of liquid meal replacements on cardiometabolic risk factors in overweight\/obese individuals with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Noronha","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100228_bib135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/obr.12816","article-title":"A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss","volume":"20","author":"Astbury","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100228_bib136","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/oby.21614","article-title":"Timing the discussion of antiobesity medications during obesity treatment","volume":"24","author":"Rebello","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102661","article-title":"GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study","volume":"73","author":"Moll","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2025.100228_bib138","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mcna.2017.08.012","article-title":"Maintenance of lost weight and long-term management of obesity","volume":"102","author":"Hall","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.obpill.2025.100228_bib139","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1039\/C5FO01530H","article-title":"Dietary protein intake and human health","volume":"7","author":"Wu","year":"2016","journal-title":"Food Funct"},{"key":"10.1016\/j.obpill.2025.100228_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Martinez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2025.100228_bib141","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jn\/138.3.439","article-title":"Metabolic effects of dietary fiber consumption and prevention of diabetes","volume":"138","author":"Weickert","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib143","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.2147\/DMSO.S494919","article-title":"Dietary recommendations for the management of gastrointestinal symptoms in patients treated with GLP-1 receptor agonist","volume":"17","author":"Gentinetta","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.obpill.2025.100228_bib144","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","article-title":"Dissociable hindbrain GLP1R circuits for satiety and aversion","volume":"632","author":"Huang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.obpill.2025.100228_bib145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.adj2537","article-title":"GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans","volume":"385","author":"Kim","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.obpill.2025.100228_bib146","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ijo.2013.149","article-title":"Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults","volume":"38","author":"Lean","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.obpill.2025.100228_bib147","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100228_bib148","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100228_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14113791","article-title":"Weight regain after liraglutide, semaglutide or tirzepatide interruption: a narrative review of randomized studies","volume":"14","author":"Quarenghi","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2025.100228_bib150","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100228_bib151","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eprac.2023.12.010","article-title":"A review of incretin therapies approved and in late-stage development for overweight and obesity management","volume":"30","author":"Chetty","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.obpill.2025.100228_bib152","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12622","article-title":"Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice","volume":"14","author":"Grannell","year":"2024","journal-title":"Clin Obes"},{"key":"10.1016\/j.obpill.2025.100228_bib153","first-page":"860","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.obpill.2025.100228_bib154","series-title":"Poster presented at: Academy of Managed Care Pharmacy 2024","article-title":"Real-world first-year cost-effectiveness assessment of glucagon-like peptide-1 agonists to treat nondiabetes obesity","author":"Leslie","year":"2024"},{"key":"10.1016\/j.obpill.2025.100228_bib155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14656566.2024.2343092","article-title":"A systematic review of the effect of semaglutide on lean mass: insights from clinical trials","volume":"25","author":"Bikou","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.obpill.2025.100228_bib156","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v16.i4.101731","article-title":"Reasons for discontinuing tirzepatide in randomized controlled trials: a systematic review and meta-analysis","volume":"16","author":"Kamrul-Hasan","year":"2025","journal-title":"World J Diabetes"},{"key":"10.1016\/j.obpill.2025.100228_bib157","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1001\/jama.2024.2603","article-title":"Tirzepatide for maintenance of weight reduction in adults with obesity-reply","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100228_bib158","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13679-023-00534-z","article-title":"The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities","volume":"12","author":"Wadden","year":"2023","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.obpill.2025.100228_bib159","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7570\/jomes20028","article-title":"Clinical evidence and mechanisms of high-protein diet-induced weight loss","volume":"29","author":"Moon","year":"2020","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.obpill.2025.100228_bib160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.obpill.2025.100228_bib161","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.obpill.2025.100228_bib162","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/oby.24172","article-title":"GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials","volume":"33","author":"Beavers","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100228_bib163","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100228_bib164","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1111\/dom.15913","article-title":"Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: filling the gaps","volume":"26","author":"Dubin","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100228_bib166","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.2024.2252","article-title":"GLP-1 agonists for Obesity-A new recipe for success?","volume":"331","author":"Mozaffarian","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100228_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2025.100491","article-title":"Examining the omission of dietary quality data in glucagon-like peptide 1 clinical trials: a scoping review","volume":"16","author":"Babazadeh","year":"2025","journal-title":"Adv Nutr"},{"key":"10.1016\/j.obpill.2025.100228_bib168","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cgh.2013.11.031","article-title":"Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials","volume":"12","author":"Stokes","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.obpill.2025.100228_bib169","series-title":"Total fat intake for the prevention of unhealthy weight gain in adults and children: WHO guideline summary","year":"2023"},{"key":"10.1016\/j.obpill.2025.100228_bib171","series-title":"Dietary Guidelines for Americans, 2020-2025","year":"2020"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368125000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368125000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:01:58Z","timestamp":1773918118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368125000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":167,"alternative-id":["S2667368125000725"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100228","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100228"}}